Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bruton’s Tyrosine Kinase (BTK) Inhibitor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bruton’s Tyrosine Kinase (BTK) Inhibitor by Country/Region, 2017, 2022 & 2028

2.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Type

2.2.1 Acalabrutinib

2.2.2 Zanubrutinib

2.2.3 Ibrutinib

2.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type

2.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

2.3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Type (2017-2022)

2.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Application

2.4.1 Tumor

2.4.2 Autoimmunity

2.5 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application

2.5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Market Share by Application (2017-2022)

2.5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Application (2017-2022)

3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor by Company

3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Breakdown Data by Company

3.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales by Company (2020-2022)

3.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Company (2020-2022)

3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Revenue by Company (2020-2022)

3.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Company (2020-2022)

3.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Company (2020-2022)

3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Company

3.4 Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Location Distribution

3.4.2 Players Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bruton’s Tyrosine Kinase (BTK) Inhibitor by Geographic Region

4.1 World Historic Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Geographic Region (2017-2022)

4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Revenue by Geographic Region

4.2 World Historic Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country/Region (2017-2022)

4.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Revenue by Country/Region

4.3 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth

4.4 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth

4.5 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth

4.6 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth

5 Americas

5.1 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country

5.1.1 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022)

5.1.2 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022)

5.2 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type

5.3 Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region

6.1.1 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2017-2022)

6.1.2 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2017-2022)

6.2 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type

6.3 APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor by Country

7.1.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022)

7.1.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022)

7.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type

7.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor by Country

8.1.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022)

8.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type

8.3 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor

10.3 Manufacturing Process Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor

10.4 Industry Chain Structure of Bruton’s Tyrosine Kinase (BTK) Inhibitor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors

11.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Customer

12 World Forecast Review for Bruton’s Tyrosine Kinase (BTK) Inhibitor by Geographic Region

12.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Forecast by Region

12.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Forecast by Region (2023-2028)

12.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Forecast by Type

12.7 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.1.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.2.3 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Principia Biopharma

13.3.1 Principia Biopharma Company Information

13.3.2 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.3.3 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Principia Biopharma Main Business Overview

13.3.5 Principia Biopharma Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.4.3 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Sunesis Pharmaceuticals

13.5.1 Sunesis Pharmaceuticals Company Information

13.5.2 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.5.3 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sunesis Pharmaceuticals Main Business Overview

13.5.5 Sunesis Pharmaceuticals Latest Developments

13.6 BeiGene

13.6.1 BeiGene Company Information

13.6.2 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.6.3 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BeiGene Main Business Overview

13.6.5 BeiGene Latest Developments

13.7 Novartis

13.7.1 Novartis Company Information

13.7.2 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.7.3 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis Main Business Overview

13.7.5 Novartis Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.8.3 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Celgene Corporation

13.9.1 Celgene Corporation Company Information

13.9.2 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.9.3 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Celgene Corporation Main Business Overview

13.9.5 Celgene Corporation Latest Developments

13.10 Loxo

13.10.1 Loxo Company Information

13.10.2 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.10.3 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Loxo Main Business Overview

13.10.5 Loxo Latest Developments

13.11 ArQule

13.11.1 ArQule Company Information

13.11.2 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.11.3 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 ArQule Main Business Overview

13.11.5 ArQule Latest Developments

13.12 Hengrui

13.12.1 Hengrui Company Information

13.12.2 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

13.12.3 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hengrui Main Business Overview

13.12.5 Hengrui Latest Developments

14 Research Findings and Conclusion

Table 1. Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bruton’s Tyrosine Kinase (BTK) Inhibitor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Acalabrutinib

Table 4. Major Players of Zanubrutinib

Table 5. Major Players of Ibrutinib

Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2017-2022) & (K Units)

Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

Table 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2017-2022) & ($ million)

Table 9. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2017-2022)

Table 10. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2017-2022) & (K Units)

Table 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Table 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2017-2022)

Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2017-2022)

Table 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Company (2020-2022) & (K Units)

Table 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Company (2020-2022)

Table 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Company (2020-2022)

Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Bruton’s Tyrosine Kinase (BTK) Inhibitor Producing Area Distribution and Sales Area

Table 22. Players Bruton’s Tyrosine Kinase (BTK) Inhibitor Products Offered

Table 23. Bruton’s Tyrosine Kinase (BTK) Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Geographic Region (2017-2022)

Table 28. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country/Region (2017-2022)

Table 32. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022) & (K Units)

Table 35. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2017-2022)

Table 36. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2017-2022)

Table 38. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2017-2022) & (K Units)

Table 39. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

Table 40. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2017-2022) & (K Units)

Table 41. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Table 42. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2017-2022) & (K Units)

Table 43. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2017-2022)

Table 44. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2017-2022)

Table 46. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2017-2022) & (K Units)

Table 47. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

Table 48. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2017-2022) & (K Units)

Table 49. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Table 50. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022) & (K Units)

Table 51. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2017-2022)

Table 52. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2017-2022)

Table 54. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2017-2022) & (K Units)

Table 55. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

Table 56. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2017-2022) & (K Units)

Table 57. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Table 67. Key Market Challenges & Risks of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Table 68. Key Industry Trends of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Table 69. Bruton’s Tyrosine Kinase (BTK) Inhibitor Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors List

Table 72. Bruton’s Tyrosine Kinase (BTK) Inhibitor Customer List

Table 73. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Forecast by Region

Table 75. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share Forecast by Application (2023-2028)

Table 93. AbbVie Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 94. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 95. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. AbbVie Main Business

Table 97. AbbVie Latest Developments

Table 98. Johnson & Johnson Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 99. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 100. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Johnson & Johnson Main Business

Table 102. Johnson & Johnson Latest Developments

Table 103. Principia Biopharma Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 104. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 105. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Principia Biopharma Main Business

Table 107. Principia Biopharma Latest Developments

Table 108. Merck Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 109. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 110. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Merck Main Business

Table 112. Merck Latest Developments

Table 113. Sunesis Pharmaceuticals Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 114. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 115. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Sunesis Pharmaceuticals Main Business

Table 117. Sunesis Pharmaceuticals Latest Developments

Table 118. BeiGene Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 119. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 120. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. BeiGene Main Business

Table 122. BeiGene Latest Developments

Table 123. Novartis Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 124. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 125. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Novartis Main Business

Table 127. Novartis Latest Developments

Table 128. Sanofi Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 129. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 130. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Sanofi Main Business

Table 132. Sanofi Latest Developments

Table 133. Celgene Corporation Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 134. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 135. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Celgene Corporation Main Business

Table 137. Celgene Corporation Latest Developments

Table 138. Loxo Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 139. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 140. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Loxo Main Business

Table 142. Loxo Latest Developments

Table 143. ArQule Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 144. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 145. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. ArQule Main Business

Table 147. ArQule Latest Developments

Table 148. Hengrui Basic Information, Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 149. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Offered

Table 150. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Hengrui Main Business

Table 152. Hengrui Latest Developments

List of Figures

Figure 1. Picture of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Figure 2. Bruton’s Tyrosine Kinase (BTK) Inhibitor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Acalabrutinib

Figure 10. Product Picture of Zanubrutinib

Figure 11. Product Picture of Ibrutinib

Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type in 2021

Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2017-2022)

Figure 14. Bruton’s Tyrosine Kinase (BTK) Inhibitor Consumed in Tumor

Figure 15. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market: Tumor (2017-2022) & (K Units)

Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitor Consumed in Autoimmunity

Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market: Autoimmunity (2017-2022) & (K Units)

Figure 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2017-2022)

Figure 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application in 2021

Figure 20. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Company in 2021

Figure 22. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Geographic Region in 2021

Figure 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2017-2022)

Figure 25. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country/Region in 2021

Figure 26. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2017-2022 (K Units)

Figure 27. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2017-2022 ($ Millions)

Figure 28. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2017-2022 (K Units)

Figure 29. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2017-2022 ($ Millions)

Figure 30. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2017-2022 (K Units)

Figure 31. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2017-2022 ($ Millions)

Figure 34. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2021

Figure 35. Americas Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2021

Figure 36. United States Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region in 2021

Figure 41. APAC Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Regions in 2021

Figure 42. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2021

Figure 49. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2021

Figure 50. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country in 2021

Figure 57. Egypt Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor in 2021

Figure 63. Manufacturing Process Analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Figure 64. Industry Chain Structure of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles